Neurovascular Intervention Devices Market by Product, Process, Indication, End-use

Description

List of Tables

[183 Pages Report] The Neurovascular Intervention Devices Market size was estimated at USD 4.01 billion in 2023 and expected to reach USD 4.25 billion in 2024, at a CAGR 6.46% to reach USD 6.21 billion by 2030.

Neurovascular intervention devices are advanced medical apparatuses designed for the treatment of neurovascular disorders that affect the blood vessels in the brain and the nervous system. These devices enable minimally invasive procedures for conditions such as aneurysms, arteriovenous malformations (AVMs), and ischemic strokes. They include stents, embolic coils, flow diverters, microcatheters, and clot retrieval devices. The application of these devices requires high precision and skilled interventional neurologists due to the complex nature of neurovascular diseases and the critical function of the nervous system. The rising prevalence of neurovascular conditions, including strokes, aneurysms, and stenosis, has driven the need for neurovascular intervention devices. There is a growing inclination toward minimally invasive surgeries over traditional surgeries due to benefits such as shorter hospital stays, reduced recovery time, and lower risk of complications. The successful implementation of neurovascular interventions is highly dependent on the availability of skilled professionals and advanced healthcare infrastructure, which can be lacking in some regions. Neurovascular interventions require high precision and skill. However, technical limitations in device design and performance, such as navigation difficulties in complex vascular structures, can lead to procedural complications. Key players are exploring ongoing research and development efforts aimed at creating more advanced, reliable, and safer neurovascular intervention devices. These include devices with improved navigability, effectiveness in clot removal, and devices that promote faster vessel healing. The integration of AI and robotics in neurovascular interventions can enhance precision, reduce procedure times, and potentially improve patient outcomes.

KEY MARKET STATISTICS
Base Year [2023]	USD 4.01 billion
Estimated Year [2024]	USD 4.25 billion
Forecast Year [2030]	USD 6.21 billion
CAGR (%)	6.46%

Regional Insights

The Americas region, particularly the U.S. and Canada, presents a highly developed landscape for neurovascular intervention devices due to its advanced healthcare infrastructure, high patient awareness, and significant investment in R&D. Customers here require innovative, minimally invasive solutions that offer quick recovery and have a strong preference for products with proven efficacy and safety. Recent patents in the U.S. have focused on enhancing device accuracy and reducing procedural complications. Canada's universal healthcare system supports patient access to these interventions, although the device approval process can be stringent. APAC's neurovascular intervention devices market is rapidly expanding, owing to its growing healthcare expenditure. The increased prevalence of neurological disorders among its aging population also necessitated the adoption of neurovascular intervention devices. Local manufacturers are investing heavily in R&D, striving to compete with international brands. Japan is a major contributor in the Asia-Pacific region due to its high healthcare spending and technological sophistication, and patients strongly prefer innovation backed by clinical evidence. The Indian market is characterized by a growing need for neurovascular treatments due to increasing healthcare awareness and improving healthcare infrastructure. EU patients generally seek high-quality, durable neurovascular devices. Recent EU initiatives have focused on harmonizing regulatory requirements to streamline device approval processes, benefitting manufacturers and patients. Stringent regulations pertaining to the performance, efficacy, safety, and manufacture of medical devices have created a standardized framework for the progress and adoption of neurovascular intervention devices.

Market Insights

Market Dynamics

The market dynamics represent an ever-changing landscape of the Neurovascular Intervention Devices Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers
- Increasing incidence of neurovascular diseases worldwide
- Growing preference for minimally invasive procedures

Market Restraints
- Lack of reimbursement scenario and product recall for neurovascular intervention devices

Market Opportunities
- Technological advancements in neurovascular intervention devices
- Rising investments in neurovascular R&D and treatment center

Market Challenges
- Technical limitations of operating neurovascular intervention devices

Market Segmentation Analysis
- Product: Fundamental role of catheters in various types of endovascular neurosurgical procedures
- Process: Proliferating utilization of neurovascular intervention devices in cerebral angiography
- Indication: Burgeoning utilization of neurovascular intervention devices for ischemic strokes
- End-use: Comprehensive facilities and specialized personnel in hospitals expanding the adoption of neurovascular intervention devices

Market Disruption Analysis
Porter's Five Forces Analysis
Value Chain & Critical Path Analysis
Pricing Analysis
Technology Analysis
Patent Analysis
Trade Analysis
Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Neurovascular Intervention Devices Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Neurovascular Intervention Devices Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Baylis Medical Technologies Introduces PowerWire Pro RF Guidewire for Enhanced Venous Stent Recanalization

Baylis Medical Technologies Inc., announced the 510(k) clearance and subsequent launch of its PowerWire Pro Radiofrequency (RF) Guidewire in the United States. Specifically engineered for venous stent recanalization in cases of complete occlusion, this innovative device utilizes radiofrequency technology to navigate through totally occluded peripheral vessel stents. [Published On: 2024-03-20]

S3V Vascular Technologies Secures Key Series B Funding of INR 300 Crore for Neurovascular Intervention Innovation, Attracting Elite Investor Interest

S3V Vascular Technologies secured a robust financial investment of INR 300 crore in Series B funding. The investment highlights a growing confidence in S3V Vascular Technologies' innovative approaches and product offerings in the neurovascular domain. This capital contributes to expanding the company's product line, enhancing its research and development capabilities, and broadening its market reach, particularly in the neurovascular intervention space. [Published On: 2024-03-15]

Nanoflex Robotics Deployed Revolutionary Remote-Operable System for Neurovascular Interventions

Nanoflex Robotics, a Switzerland-based innovator, deployed its remote-capable robotics system at the Jacobs Institute in Buffalo, USA, marking a significant advancement in neurovascular intervention technology. The system integrates a compact magnetic field generator with a navigation control unit, enabling physicians to precisely control, maneuver, and guide ultra-flexible devices through the intricate pathways of the body's vasculature. This breakthrough technology facilitates a wide array of complex vascular interventions by allowing direct manipulation of the guidewire's tip, dramatically enhancing the precision and safety of these procedures. [Published On: 2024-03-11]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Neurovascular Intervention Devices Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Neurovascular Intervention Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Acandis GmbH, Asahi Intecc Co., Ltd., Balt Group, Boston Scientific Corporation, Carl Zeiss AG, Edwards Lifesciences Corporation, Evasc Medical Systems Corp., GE Healthcare, Imperative Care Inc., Integer Holdings Corporation, Japan Lifeline Co., Johnson & Johnson Services, Inc., Koninklijke Philips N.V., Lepu Medical Technology (Beijing) Co., Ltd., LivaNova PLC, Medikit Co., Ltd., Medtronic PLC, Merit Medical Systems, Inc., Microport Scientific Corporation, Nanoflex Robotics AG, NeuroSafe Medical Co., Ltd., Penumbra, Inc., Phenox GmbH by Wallaby Medical, LLC, Rapid Medical Ltd., Route 92 Medical, Inc., Siemens Healthineers AG, Stryker Corporation, Terumo Corporation, and Zylox-Tonbridge Medical Technology Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Neurovascular Intervention Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
- Balloon Systems
- Carotid Stents
- Catheters
- Embolic Coils
- Embolic Protection Devices
- Flow Diverters
- Guidewires
- Intracranial Stents
- Intrasaccular Devices
- Neurothrombectomy Devices
  - Aspiration Devices
  - Stent Retrievers
  - Ultrasound-assisted Devices
Process
- Carotid Endarterectomy
- Cerebral Angiography
- Coiling
- Flow Diversion
- Microsurgical Clipping
- Neurothrombectomy
- Stenting

Indication
- Arteriovenous Malformations
- Cerebral Aneurysms
- Ischemic Strokes
- Stenosis Treatment

End-use
- Ambulatory Surgical Centers
- Hospitals
- Speciality Clinics

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam

Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom

Product Code: MRR-ED54C46E8FA1

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Increasing incidence of neurovascular diseases worldwide
  - 5.1.1.2. Growing preference for minimally invasive procedures
- 5.1.2. Restraints
  - 5.1.2.1. Lack of reimbursement scenario and product recall for neurovascular intervention devices
- 5.1.3. Opportunities
  - 5.1.3.1. Technological advancements in neurovascular intervention devices
  - 5.1.3.2. Rising investments in neurovascular R&D and treatment center
- 5.1.4. Challenges
  - 5.1.4.1. Technical limitations of operating neurovascular intervention devices
5.2. Market Segmentation Analysis
- 5.2.1. Product: Fundamental role of catheters in various types of endovascular neurosurgical procedures
- 5.2.2. Process: Proliferating utilization of neurovascular intervention devices in cerebral angiography
- 5.2.3. Indication: Burgeoning utilization of neurovascular intervention devices for ischemic strokes
- 5.2.4. End-use: Comprehensive facilities and specialized personnel in hospitals expanding the adoption of neurovascular intervention devices
5.3. Market Trend Analysis
- 5.3.1. Advancing neurovascular healthcare infrastructure in the Americas and the presence of established intervention device providers
- 5.3.2. Technological innovations and robust healthcare infrastructure driving use of neurovascular intervention devices in the APAC region
- 5.3.3. Growing approvals for neurovascular intervention devices from regulatory authorities in the EMEA region
5.4. Cumulative Impact of High Inflation
5.5. Porter's Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework Analysis

6. Neurovascular Intervention Devices Market, by Product

6.1. Introduction
6.2. Balloon Systems
6.3. Carotid Stents
6.4. Catheters
6.5. Embolic Coils
6.6. Embolic Protection Devices
6.7. Flow Diverters
6.8. Guidewires
6.9. Intracranial Stents
6.10. Intrasaccular Devices
6.11. Neurothrombectomy Devices

7. Neurovascular Intervention Devices Market, by Process

7.1. Introduction
7.2. Carotid Endarterectomy
7.3. Cerebral Angiography
7.4. Coiling
7.5. Flow Diversion
7.6. Microsurgical Clipping
7.7. Neurothrombectomy
7.8. Stenting

8. Neurovascular Intervention Devices Market, by Indication

8.1. Introduction
8.2. Arteriovenous Malformations
8.3. Cerebral Aneurysms
8.4. Ischemic Strokes
8.5. Stenosis Treatment

9. Neurovascular Intervention Devices Market, by End-use

9.1. Introduction
9.2. Ambulatory Surgical Centers
9.3. Hospitals
9.4. Speciality Clinics

10. Americas Neurovascular Intervention Devices Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Neurovascular Intervention Devices Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Neurovascular Intervention Devices Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
- 13.3.1. Baylis Medical Technologies Introduces PowerWire Pro RF Guidewire for Enhanced Venous Stent Recanalization
- 13.3.2. S3V Vascular Technologies Secures Key Series B Funding of INR 300 Crore for Neurovascular Intervention Innovation, Attracting Elite Investor Interest
- 13.3.3. Nanoflex Robotics Deployed Revolutionary Remote-Operable System for Neurovascular Interventions
- 13.3.4. Zylox-Tonbridge Forms Strategic Alliance with Avinger to Innovate Neurovascular Interventions in Greater China
- 13.3.5. Philips Unveils Advanced Azurion Neuro Biplane Interventional System
- 13.3.6. Introducing CEREGLIDE 71 a CERENOVUS's Breakthrough in Stroke Intervention with TruCourse Technology
- 13.3.7. OrbusNeich and Abbott's CSI Extend Exclusive Distribution Partnership in the U.S. through 2027
- 13.3.8. Sensome and Asahi Intecc Collaborate on Advanced AI-Powered Clotild Smart Guidewire
- 13.3.9. Stryker's Acquired Cerus Endovascular to Expand its Offering in the Neurovascular Intervention Sector
- 13.3.10. Infinity Neuro Secures CE Mark for Inspira Aspiration Catheters

14. Competitive Portfolio

14.1. Key Company Profiles
14.2. Key Product Portfolio